Answers are grounded in this paper and cite their sources.
Prospective follow-up study shows normalized liver enzymes and lower cholesterol after switching to oxcarbazepine in epilepsy, suggesting better lipid metabolism.
We evaluated liver P450 enzyme system induction and serum lipid levels in a prospective follow-up study in 12 male patients with epilepsy after replacing carbamazepine (CBZ) medication with oxcarbazepine (OCBZ). Antipyrine(t1/2) increased and antipyrine(CL) decreased 2 months after the medication was changed, reflecting normalization of liver P450 enzyme system function. Furthermore, serum total cholesterol levels decreased, but serum concentrations of high-density lipoprotein (HDL)-cholesterol and triglycerides (TG) were unchanged. OCBZ may be the preferable antiepileptic drug (AED) with regard to the effects of the medication on lipid metabolism.
No takes yet. Share an insight, caveat, or question.
Isojärvi et al. (1994) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: